Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

6.18
Delayed Data
As of 4:00pm ET
 -0.02 / -0.32%
Today’s Change
1.53
Today|||52-Week Range
8.84
+202.94%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close6.20
Today’s open6.26
Day’s range6.17 - 6.54
Volume2,567,319
Average volume (3 months)3,449,780
Market cap$959.6M
Dividend yield--
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+38.87%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.45-4.97%
NTLAIntellia Therapeutic...-2.08-9.80%
MYOVMyovant Sciences Ltd-0.58-4.81%
CRSPCRISPR Therapeutics ...-0.47-2.49%
Data as of 4:02pm ET, 12/11/2017

Financials

Next reporting dateFebruary 16, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts